Mercury Laboratories Intrinsic Value
Mercury Laboratories (MERCURYLAB) median intrinsic value is ₹725.02 from 9 valuation models (range ₹256–₹1520), vs current price ₹840.00 — -13.7% downside (Trading Above Median Value), margin of safety -15.9%. Also explore MERCURYLAB share price data to track price trends across different timeframes.
MERCURYLAB Valuation Methods Summary — DCF, Graham Number & P/E
Mercury Laboratories intrinsic value across 9 models vs current price ₹840.00 — upside/downside and value range per method. Browse MERCURYLAB cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹886.16 | ₹708.93 - ₹1063.39 | +5.5% | EPS: ₹40.28, Sector P/E: 22x |
| Book Value Method | asset | ₹1160.00 | ₹1044.00 - ₹1276.00 | +38.1% | Book Value/Share: ₹580.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1520.00 | ₹1368.00 - ₹1672.00 | +81.0% | Revenue/Share: ₹760.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹900.00 | ₹810.00 - ₹990.00 | +7.1% | EBITDA: ₹9.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹371.35 | ₹297.08 - ₹445.62 | -55.8% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹255.65 | ₹230.09 - ₹281.22 | -69.6% | EPS Growth: 7.9%, Fair P/E: 6.3x |
| Growth Adjusted P/E | growth | ₹623.94 | ₹561.55 - ₹686.33 | -25.7% | Revenue Growth: 6.5%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹500.00 | ₹450.00 - ₹550.00 | -40.5% | ROE: 8.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹725.02 | ₹652.52 - ₹797.52 | -13.7% | EPS: ₹40.28, BVPS: ₹580.00 |
MERCURYLAB Intrinsic Value vs Market Price — All Valuation Models
Mercury Laboratories fair value range ₹256–₹1520 vs current market price ₹840.00 across 9 valuation models. For current market price and key ratios, visit Mercury Laboratories share price today.
MERCURYLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Mercury Laboratories median intrinsic value ₹725.02, current price ₹840.00 — Trading Above Median Value by 13.7%, margin of safety -15.9%.
What is the intrinsic value of MERCURYLAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Mercury Laboratories (MERCURYLAB) is ₹725.02 (median value). With the current market price of ₹840.00, this represents a -13.7% variance from our estimated fair value.
The valuation range spans from ₹255.65 to ₹1520.00, indicating ₹255.65 - ₹1520.00.
Is MERCURYLAB undervalued or overvalued?
Based on our multi-method analysis, Mercury Laboratories (MERCURYLAB) appears to be trading above median value by approximately 13.7%.
MERCURYLAB Financial Health — Key Ratios vs Industry Benchmarks
Mercury Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.96x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
MERCURYLAB Cash Flow Quality — Operating & Free Cash Flow
Mercury Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹4 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹8 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹8 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |